JP2019518050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518050A5
JP2019518050A5 JP2018565691A JP2018565691A JP2019518050A5 JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5 JP 2018565691 A JP2018565691 A JP 2018565691A JP 2018565691 A JP2018565691 A JP 2018565691A JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
compound
substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018565691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/064654 external-priority patent/WO2017216283A1/en
Publication of JP2019518050A publication Critical patent/JP2019518050A/ja
Publication of JP2019518050A5 publication Critical patent/JP2019518050A5/ja
Pending legal-status Critical Current

Links

JP2018565691A 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物 Pending JP2019518050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16174722.5 2016-06-16
EP16174722 2016-06-16
PCT/EP2017/064654 WO2017216283A1 (en) 2016-06-16 2017-06-15 Heterocyclic compounds as antibacte rials

Publications (2)

Publication Number Publication Date
JP2019518050A JP2019518050A (ja) 2019-06-27
JP2019518050A5 true JP2019518050A5 (https=) 2020-08-13

Family

ID=56132839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018565691A Pending JP2019518050A (ja) 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物

Country Status (12)

Country Link
US (1) US20200308169A1 (https=)
EP (1) EP3472152A1 (https=)
JP (1) JP2019518050A (https=)
KR (1) KR20190018681A (https=)
CN (1) CN109415349A (https=)
AU (1) AU2017286370B2 (https=)
BR (1) BR112018075939A2 (https=)
CA (1) CA3025727A1 (https=)
EA (1) EA201990044A1 (https=)
MA (1) MA45375A (https=)
MX (1) MX2018015657A (https=)
WO (1) WO2017216283A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA125171C2 (uk) 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
KR20180053386A (ko) 2015-09-17 2018-05-21 마빈 제이. 밀러 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물
JP2019518046A (ja) 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
KR20190121315A (ko) 2017-03-01 2019-10-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 병용 요법
TWI861208B (zh) 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
US20220340564A1 (en) 2019-09-13 2022-10-27 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
CN114450288A (zh) 2019-09-30 2022-05-06 爱尔兰詹森科学公司 4-喹啉酮抗细菌化合物
MX2022003816A (es) 2019-09-30 2022-05-06 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
MX2023010947A (es) 2021-03-16 2023-11-29 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
CA3211592A1 (en) 2021-03-17 2022-09-22 Jerome Emile Georges Guillemont Antibacterial compounds
MX2023010941A (es) 2021-03-17 2023-11-28 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
WO2022214519A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2022214520A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
EP4423097A1 (en) 2021-10-28 2024-09-04 Janssen Sciences Ireland Unlimited Company Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
TW202340187A (zh) * 2021-12-20 2023-10-16 加拿大商費爾哈芬製藥公司 Oxer1拮抗劑及其用途
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE463482T1 (de) 2002-07-25 2010-04-15 Janssen Pharmaceutica Nv Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
SG184073A1 (en) 2010-03-18 2012-10-30 Pasteur Institut Korea Anti-infective compounds
CN103797011B (zh) 2011-09-01 2016-03-30 诺华股份有限公司 作为c-Kit激酶抑制剂的化合物和组合物
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
US9605002B2 (en) * 2012-07-18 2017-03-28 University Of Notre Dame Du Lac 5,5-heteroaromatic anti-infective compounds
JP2016525562A (ja) * 2013-08-02 2016-08-25 インスティチュート パスツール コリア 抗感染症化合物
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2019518050A5 (https=)
JP2019518046A5 (https=)
JP2018519302A5 (https=)
JP2018524339A5 (https=)
JP2020169171A5 (https=)
JP2019526596A5 (https=)
JP2017524025A5 (https=)
JP2014500295A5 (https=)
JP2016530259A5 (https=)
JP2019510787A5 (https=)
JP2003128673A5 (https=)
JP2013532652A5 (https=)
MX2011002348A (es) Terapia de combinacion para tuberculosis.
HU229935B1 (en) Dual action antibiotics
JP2019527724A5 (https=)
JP2021501756A5 (https=)
JP2022500425A5 (https=)
JP2013542267A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2011526247A5 (https=)
JPWO2021030556A5 (https=)
JP2019520344A5 (https=)
JP2011509302A5 (https=)
JOP20240217A1 (ar) مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة
JP2018536678A5 (https=)